NCT03256344
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1
Drug Category: Immunotherapy, Therapeutic Antibody
Key Eligibility Criteria:
Gender: All
Age: 18 Years to 99 Years (Adult, Senior)
Location of Metastases: Liver
Additional Notes:
Exclusions: Active or untreated central nervous system (CNS) metastases
https://ClinicalTrials.gov/show/NCT03256344